Success Story: Dual Immigration Victory! Senior Lecturer Secures NIW & EB1A Approvals with Premium Processing - Even with EB1A RFE
Client’s Testimonial:
“Your services are excellent. I am thrilled to learn about the successful outcome of your hard work and commitment to my case. I greatly appreciate the efforts of your firm. Thank you so much for everything.”
On February 14th, 2024, and February 27th, 2025, we received another I-140 NIW (National Interest Waiver) and EB1A (Alien of Extraordinary Ability) Approvals for a Senior Lecturer (Approval Notice).
General Field: Public Health
Position at the Time of Case Filing: Senior Lecturer
Approval Notice Date: : February 14th, 2024 (NIW); February 27th, 2025 (EB1A)
Processing Time: 13 days (NIW), and 2 months, 25 days (EB1A) (Premium Processing Requested)
Case Summary:
We’re pleased to share the approval of both the I-140 National Interest Waiver (NIW) and EB1A immigrant petitions for a highly accomplished public health expert specializing in infectious diseases, global health, and biostatistics.
With an M.B.B.S. degree and deep expertise in epidemiological research, the petitioner has made significant contributions to understanding health behaviors and vaccine uptake, particularly in underserved populations. Her work is particularly notable for investigating immunization knowledge, attitudes, and behaviors in Nigeria - a topic with wide-reaching implications for public health systems globally.
Currently engaged in academic and research roles, the petitioner’s work bridges scientific evidence and population-level health interventions. She has published 35 peer-reviewed journal articles, including 8 as first author, and 1 abstract. Collectively, her research has been cited 356 times, reflecting her influence across the global health research community. Her findings have shaped discussions on public health interventions, particularly within the context of improving immunization and disease prevention strategies in low- and middle-income countries.
The petitioner’s expertise has also been recognized through her active involvement in scholarly peer review, having completed at least 16 reviews for respected public health journals. This level of engagement reflects her stature in the field and the trust that editors place in her scientific judgment.
Her achievements were further supported by four strong recommendation letters, which were submitted with the EB1A petition. These letters came from both independent and affiliated experts who praised her leadership in the field of infectious disease epidemiology and highlighted her work as essential to improving global public health outcomes.
“Ensuring the continuation of the petitioner's work is thus deeply important to both public health research and to the nation, and his work must be allowed to continue.”
In addition to presenting strong publication and citation metrics, we established the petitioner’s significance through a clear demonstration of how her work addresses pressing national and international health challenges. Her research aligns closely with U.S. public health goals, particularly those related to disease prevention, immunization equity, and data-driven policy interventions.
After receiving a request for evidence (RFE) in the EB1A process, we presented a carefully constructed legal response that clearly articulated the national and international impact of her work. The result was a successful approval of both petitions.
We congratulate this exceptional physician-researcher and look forward to her continued impact in strengthening public health systems worldwide.